Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

12.3%

165 terminated/withdrawn out of 1337 trials

Success Rate

84.2%

-2.3% vs industry average

Late-Stage Pipeline

9%

126 trials in Phase 3/4

Results Transparency

40%

349 of 881 completed trials have results

Key Signals

165 recruiting349 with results117 terminated48 withdrawn

Enrollment Performance

Analytics

N/A
589(57.2%)
Phase 2
170(16.5%)
Phase 1
116(11.3%)
Phase 4
94(9.1%)
Phase 3
32(3.1%)
Early Phase 1
29(2.8%)
1030Total
N/A(589)
Phase 2(170)
Phase 1(116)
Phase 4(94)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (1337)

Showing 20 of 1337 trials
NCT04265053Early Phase 1Completed

Human Cerebral Blood Flow Regulation

Role: lead

NCT06342375Not ApplicableRecruiting

Enrollment Barriers, Procedural Denials, and Loss of Medicaid Coverage

Role: lead

NCT05807061Not ApplicableCompleted

Reducing Children's Racial Biases Via a Parent-Led Intervention

Role: lead

NCT07298967Not ApplicableSuspended

ORCHARDS-AIR Study

Role: lead

NCT07139132Not ApplicableRecruiting

The AHA Oneida Study

Role: lead

NCT06689930Not ApplicableRecruiting

Community-based Implementation of Adapted STAC

Role: lead

NCT05835999Phase 2Active Not Recruiting

Everolimus Aging Study

Role: lead

NCT03936478Phase 2Recruiting

Real-Time MRI-Guided 3-Fraction Accelerated Partial Breast Irradiation in Early Breast Cancer

Role: lead

NCT04020276Not ApplicableRecruiting

OAR-Based, Dose Escalated SBRT With Real Time Adaptive MRI Guidance for Liver Metastases

Role: lead

NCT07213921Not ApplicableActive Not Recruiting

Dermabrasion in Mohs: Split-Scar Trial

Role: lead

NCT06109571Not ApplicableActive Not Recruiting

Clinic-level Implementation of mHealth to Improve HIV Viral Suppression for Patients With Substance Use Disorders

Role: lead

NCT07475117Not ApplicableNot Yet Recruiting

Health Engagement & Access Through Learning, Training, and Health-coaching With People With Intellectual and/or Developmental Disabilities

Role: lead

NCT06407232Phase 3Recruiting

Letermovir (Prevymis) for CMV in Kidney and Pancreas Transplant Recipients

Role: lead

NCT07498270Not ApplicableRecruiting

Location- and Frequency-Dependent Effects of Thalamic Temporal Interference Stimulation During Sleep

Role: lead

NCT07634939Not Yet Recruiting

Liver Micro Flow - MRI

Role: lead

NCT06675357Phase 2Recruiting

Using FAPI PET/MRI to Evaluate Prostate Cancer

Role: lead

NCT04587128Phase 2Active Not Recruiting

Early-Line Anti-EGFR Therapy to Facilitate Retreatment for Select Patients With mCRC

Role: lead

NCT07192133Phase 2Recruiting

Evaluation of CT-XPI

Role: lead

NCT06295744Not ApplicableRecruiting

Outcomes and Cosmesis With Whole Breast Irradiation and Boost

Role: lead

NCT07573540Not ApplicableRecruiting

Optimizing Smart Technology for Addiction Recovery

Role: lead